Search research articles
Contact Us
Filters
Showing results (31-40 of 149) with videos related to
Page
of 15
Sort By:
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
October 31, 2003
Assessment of Kupffer cells by ferumoxides-enhanced MR imaging is beneficial for diagnosis of hepatocellular carcinoma: comparison of pathological diagnosis and perfusion patterns assessed by CT hepatic arteriography and CT arterioportography
Yasuhiro Asahina, Namiki Izumi, Masakatsu Uchihara, et al.
Liver Cancer
|
September 28, 2023
IMbrave150: Efficacy and Safety of Atezolizumab plus Bevacizumab versus Sorafenib in Patients with Barcelona Clinic Liver Cancer Stage B Unresectable Hepatocellular Carcinoma: An Exploratory Analysis of the Phase III Study
Masatoshi Kudo, Richard S Finn, Peter R Galle, et al.
Journal of Gastroenterology and Hepatology
|
May 19, 2022
Validation of magnetic resonance elastography plus fibrosis-4 for significant fibrosis in nonalcoholic fatty liver disease
Kento Inada, Nobuharu Tamaki, Masayuki Kurosaki, et al.
Diagnostics (Basel, Switzerland)
|
April 3, 2020
Use of the Serum <i>Wisteria floribunda</i> Agglutinin-Positive Mac2 Binding Protein as a Marker of Gastroesophageal Varices and Liver-Related Events in Chronic Hepatitis C Patients
Tsuguru Hayashi, Nobuharu Tamaki, Masayuki Kurosaki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
January 5, 2023
Cabozantinib in Japanese patients with advanced hepatocellular carcinoma: Final results of a multicenter phase II study
Naoya Kato, Masatoshi Kudo, Kaoru Tsuchiya, et al.
Journal of Gastroenterology
|
December 17, 2013
Non-invasive prediction of hepatocellular carcinoma development using serum fibrosis marker in chronic hepatitis C patients
Nobuharu Tamaki, Masayuki Kurosaki, Shuya Matsuda, et al.
Oncology
|
November 28, 2014
Transarterial chemoembolization failure/refractoriness: JSH-LCSGJ criteria 2014 update
Masatoshi Kudo, Osamu Matsui, Namiki Izumi, et al.
Scientific Reports
|
March 23, 2017
Serum Wisteria Floribunda Agglutinin-Positive Sialylated Mucin 1 as a Marker of Progenitor/Biliary Features in Hepatocellular Carcinoma
Nobuharu Tamaki, Atsushi Kuno, Atsushi Matsuda, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology
|
January 21, 2025
Effect of Proteinuria Before Lenvatinib Administration on Treatment Response After Atezolizumab Bevacizumab Combination Therapy
Hironori Ochi, Masayuki Kurosaki, Takaaki Tanaka, et al.
Digestive Diseases (Basel, Switzerland)
|
December 22, 2012
Retreatment with peginterferon α-2a + ribavirin in patients who failed previous peginterferon α-2b + ribavirin combination therapy
Taisuke Ueda, Kaoru Tsuchiya, Satoru Hashimoto, et al.
Page
of 15
Search research articles
Search
Showing results (31-40 of 149) with videos related to
Sort By:
Page
of 15
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
October 31, 2003
Assessment of Kupffer cells by ferumoxides-enhanced MR imaging is beneficial for diagnosis of hepatocellular carcinoma: comparison of pathological diagnosis and perfusion patterns assessed by CT hepatic arteriography and CT arterioportography
Yasuhiro Asahina, Namiki Izumi, Masakatsu Uchihara, et al.
Liver Cancer
|
September 28, 2023
IMbrave150: Efficacy and Safety of Atezolizumab plus Bevacizumab versus Sorafenib in Patients with Barcelona Clinic Liver Cancer Stage B Unresectable Hepatocellular Carcinoma: An Exploratory Analysis of the Phase III Study
Masatoshi Kudo, Richard S Finn, Peter R Galle, et al.
Journal of Gastroenterology and Hepatology
|
May 19, 2022
Validation of magnetic resonance elastography plus fibrosis-4 for significant fibrosis in nonalcoholic fatty liver disease
Kento Inada, Nobuharu Tamaki, Masayuki Kurosaki, et al.
Diagnostics (Basel, Switzerland)
|
April 3, 2020
Use of the Serum <i>Wisteria floribunda</i> Agglutinin-Positive Mac2 Binding Protein as a Marker of Gastroesophageal Varices and Liver-Related Events in Chronic Hepatitis C Patients
Tsuguru Hayashi, Nobuharu Tamaki, Masayuki Kurosaki, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology
|
January 5, 2023
Cabozantinib in Japanese patients with advanced hepatocellular carcinoma: Final results of a multicenter phase II study
Naoya Kato, Masatoshi Kudo, Kaoru Tsuchiya, et al.
Journal of Gastroenterology
|
December 17, 2013
Non-invasive prediction of hepatocellular carcinoma development using serum fibrosis marker in chronic hepatitis C patients
Nobuharu Tamaki, Masayuki Kurosaki, Shuya Matsuda, et al.
Oncology
|
November 28, 2014
Transarterial chemoembolization failure/refractoriness: JSH-LCSGJ criteria 2014 update
Masatoshi Kudo, Osamu Matsui, Namiki Izumi, et al.
Scientific Reports
|
March 23, 2017
Serum Wisteria Floribunda Agglutinin-Positive Sialylated Mucin 1 as a Marker of Progenitor/Biliary Features in Hepatocellular Carcinoma
Nobuharu Tamaki, Atsushi Kuno, Atsushi Matsuda, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology
|
January 21, 2025
Effect of Proteinuria Before Lenvatinib Administration on Treatment Response After Atezolizumab Bevacizumab Combination Therapy
Hironori Ochi, Masayuki Kurosaki, Takaaki Tanaka, et al.
Digestive Diseases (Basel, Switzerland)
|
December 22, 2012
Retreatment with peginterferon α-2a + ribavirin in patients who failed previous peginterferon α-2b + ribavirin combination therapy
Taisuke Ueda, Kaoru Tsuchiya, Satoru Hashimoto, et al.
Page
of 15